TABLE 2.

Metabolite ratios on MRS samplings of HSP patients and control group at baseline.

	R pre-central			L pre-central			R pre-frontal			L pre-frontal
	Patients	Control	p-value	Patients	Control	p-value	Patients	Control	p-value	Patients	Control	p-value
	(n = 31)	(n = 31)		(n = 31)	(n = 31)		(n = 16)	(n = 14)		(n = 16)	(n = 14)
NAA/Cr	1.72 ± 0.21	1.74 ± 0.18	ns	1.75 ± 0.16	1.81 ± 0.15	ns	1.70 ± 0.16	1.84 ± 0.20	0.040	1.95 ± 0.29	2.09 ± 0.21	ns
Cho/Cr	0.77 ± 0.13	0.70 ± 0.11	0.032	0.75 ± 0.14	0.77 ± 0.12	ns	0.74 ± 0.11	0.75 ± 0.15	ns	0.73 ± 0.11	0.78 ± 0.13	ns
myo-Ins/Cr	0.61 ± 0.24	0.56 ± 0.08	ns	0.64 ± 0.12	0.57 ± 0.09	0.018	0.66 ± 0.14	0.61 ± 0.12	ns	0.64 ± 0.16	0.62 ± 0.08	ns

NAA, N-acetyl-aspartate; Cr, creatine; Cho, choline; myo-Ins, myo-inositol; ns, not significant. Bold characters represent values with p < 0.05.